Co-purification of soluble membrane cofactor protein (CD46) and human herpesvirus 6 variant A genome in serum from multiple sclerosis patients
- 30 June 2005
- journal article
- Published by Elsevier in Virus Research
- Vol. 110 (1-2) , 57-63
- https://doi.org/10.1016/j.virusres.2005.01.005
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Beta-Interferon Treatment Reduces Human Herpesvirus-6 Viral Load in Multiple Sclerosis Relapses but Not in RemissionEuropean Neurology, 2004
- A CD46CD[55–46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell–cell fusion induced by CD46-using measles virusJournal of General Virology, 2002
- Increased detection of serum HHV-6 DNA sequences during multiple sclerosis (MS) exacerbations and correlation with parameters of MS disease progressionJournal of NeuroVirology, 2002
- Tissue Distribution and Variant Characterization of Human Herpesvirus (HHV)–6: Increased Prevalence of HHV‐6A in Patients with Multiple SclerosisThe Journal of Infectious Diseases, 2000
- Octamerization Enables Soluble CD46 Receptor To Neutralize Measles Virus In Vitro and In VivoJournal of Virology, 2000
- Human herpesvirus 6Reviews in Medical Virology, 2000
- Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patientsJournal of Clinical Virology, 2000
- Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary reportMultiple Sclerosis Journal, 1998
- A functional analysis of recombinant soluble CD46 in vivo and a comparison with recombinant soluble forms of CD55 and CD35 in vitroEuropean Journal of Immunology, 1996
- The human CD46 molecule is a receptor for measles virus (Edmonston strain)Cell, 1993